Scholars Central

EditorialPublished 25 Sep 2021

Apheresis in Neurological Disorders Treatment

Authors: Erica Bronen

Clinical Investigation

Volume 11 · Issue 7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In a variety of medical sectors, Plasma Exchange (PE) and Immunoadsorption (IA) are important therapy alternatives for autoimmune illnesses. Their pathophysiological explanation is primarily focused on the removal of autoantibodies and the maintenance of a healthy immune system. Apheresis is a promising therapy strategy from a theoretical aspect since it works by eliminating pathogenic components rather than administering drugs that can have major side effects. The neurological indications include Multiple Sclerosis (MS) steroid-refractory recurrence, myasthenia gravis, Autoimmune Encephalitis (AE), Guillain-Barre Syndrome (GBS), and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Erica Bronen”